Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jakub J. Regieli"'
Publikováno v:
European journal of preventive cardiology
Autor:
Jakub J. Regieli, René H.P. Mieremet, Wouter P. te Rijdt, Thirsa Kraaijenbrink, Sabrina Z. Jan, Henny H. Lemmink, Peter de Knijff, Yvonne M. Hoedemaekers
Publikováno v:
Circulation. Genomic and Precision Medicine, 13
Circulation. Genomic and Precision Medicine, 13, 2
Circulation-Genomic and precision medicine, 13(4):002674, 83-84. LIPPINCOTT WILLIAMS & WILKINS
Circulation. Genomic and Precision Medicine, 13, 2
Circulation-Genomic and precision medicine, 13(4):002674, 83-84. LIPPINCOTT WILLIAMS & WILKINS
Contains fulltext : 220426.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3465483470b3f2f6363e1b70f86164e
http://hdl.handle.net/2066/220426
http://hdl.handle.net/2066/220426
Publikováno v:
European Journal of Clinical Investigation. 50
Autor:
Maarten J. Cramer, Gertjan T. Sieswerda, Jakub J. Regieli, Hendrik M. Nathoe, Annette F. Baas
Publikováno v:
European Journal of Preventive Cardiology
Background Initial studies have suggested the familial clustering of mitral valve prolapse, but most of them were either community based among unselected individuals or applied non-specific diagnostic criteria. Therefore little is known about the fam
Autor:
Remco B. Grobben, Margot E. Tesselaar, Ronald C.A. Meijer, Hendrik M. Nathoe, Jakub J. Regieli, Marcel Th. B. Twickler, Einar A. Hart, Steven A. J. Chamuleau
Publikováno v:
Endocrinology ISBN: 9783319663623
Endocrinology
Endocrinology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15250d0ee9e92279dbdf761cc0f778cb
https://doi.org/10.1007/978-3-319-66362-3_3-1
https://doi.org/10.1007/978-3-319-66362-3_3-1
Autor:
Anton E Tuinenburg, Jakub J. Regieli
Publikováno v:
European journal of preventive cardiology. 25(14)
Autor:
Yvonne M. Hoedemaekers, Eric A. M. Hennekam, Jan van Wijngaarden, Ludolf G. Boven, Jan D. H. Jongbloed, Aryan Vink, Yigal M. Pinto, Edgar T. Hoorntje, Maarten P. van den Berg, Karin Y. van Spaendonck-Zwarts, Jakub J. Regieli, J. Peter van Tintelen, Daniela Q.C.M. Barge-Schaapveld, Folkert W. Asselbergs, Wouter P. te Rijdt, Marianne Bootsma, Jasper J. van der Smagt, Ronald H. Lekanne Deprez
Publikováno v:
European Journal of Heart Failure, 20(4), 803
European Journal of Heart Failure, 20(4), 803-806. Wiley
European journal of heart failure, 20(4), 803-806. Wiley-Blackwell
European Journal of Heart Failure, 20(4), 803-806. Wiley
European journal of heart failure, 20(4), 803-806. Wiley-Blackwell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59bda5c7031a851c62979a8c8eaa0cd4
https://doi.org/10.1002/ejhf.1030
https://doi.org/10.1002/ejhf.1030
Autor:
Jakub J. Regieli, Dieuwke S. Veldhuijzen, Hendrik M. Nathoe, Anne-Mette C. Sauër, Diederik van Dijk, Pieter A. Doevendans, Jeroen Hendrikse, Linda M. Peelen, Cor J. Kalkman, Diederick E. Grobbee
Publikováno v:
The Annals of Thoracic Surgery. 96:1294-1300
Background Off-pump coronary artery bypass grafting and percutaneous coronary intervention are both associated with cognitive decline, but limited data are available on long-term outcomes. This study compared long-term cognitive outcomes between pati
Autor:
Diederick E. Grobbee, Aeilko H. Zwinderman, John J.P. Kastelein, Jakub J. Regieli, Pieter A. Doevendans, J. Wouter Jukema, Yolanda van der Graaf
Publikováno v:
Journal of the American College of Cardiology. 54(14):1238-1245
Objectives We investigated the effects of paraoxonase (PON)-1 variants on long-term clinical outcome in patients with coronary artery disease (CAD). Background PON-1 is a potential therapeutic target to further reduce cardiovascular risk because it i
Autor:
Jakub J. Regieli, Diederick E. Grobbee, Yolanda van der Graaf, John J.P. Kastelein, Pieter A. Doevendans, J. Wouter Jukema, Aeilko H. Zwinderman
Publikováno v:
Diabetes Care
Diabetes care, 32(5), 839-844. American Diabetes Association Inc.
Diabetes care, 32(5), 839-844. American Diabetes Association Inc.
OBJECTIVE Activation of peroxisome proliferator–activated receptor (PPAR)-γ signaling influences metabolic profiles and the propensity toward inflammation. Small-molecule stimulation of PPARγ is investigated for secondary prevention of cardiovasc